Loading...
Paracetamol
India Pharmaceutical Trade Intelligence
Who Supplies Paracetamol to India from MEXICO
India's paracetamol imports from MEXICO total $686.3K across 27 shipments from 1 foreign suppliers. HELM DE MEXICO S.A leads with $686.3K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include SRI KRISHNA PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for paracetamol — a concentrated sourcing relationship with select suppliers from MEXICO.
Top foreign suppliers (MEXICO) — Ranked by import value
HELM DE MEXICO S.A is the leading Paracetamol supplier from MEXICO to India, with import value of $686.3K across 27 shipments. The top 5 suppliers — HELM DE MEXICO S.A — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (MEXICO)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | HELM DE MEXICO S.A | $686.3K | 27 | 100.0% |
Showing top 1 of 1 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from MEXICO)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SRI KRISHNA PHARMACEUTICALS LIMITED | $686.3K | 27 | 100.0% |
Import Statistics
- Import Value
- $686.3K
- Shipments
- 27
- Foreign Suppliers
- 1
- Indian Buyers
- 1
- Avg. Shipment
- $25.4K
Other Paracetamol Import Origins
Related Analysis
India Import License & CDSCO Registration
MEXICO → India trade corridor intelligence
1India Import License & CDSCO Registration
To import finished pharmaceutical formulations containing Paracetamol (HS Code 30049069) into India, the following regulatory steps are mandatory:
- 1Import License: Obtain an Importer Exporter Code (IEC) from the Directorate General of Foreign Trade (DGFT).
- 2CDSCO Registration: Secure registration from the Central Drugs Standard Control Organisation (CDSCO) for the specific formulation.
- 3Form CT-20/40/41: Depending on the product type, submit the appropriate application form to CDSCO.
- 4DCGI Approval: Ensure approval from the Drugs Controller General of India (DCGI) for the imported product.
- 5No Objection Certificate (NOC): If required, obtain an NOC from the Ministry of Health and Family Welfare.
The registration process typically spans 6 to 12 months, contingent upon the completeness of the application and compliance with all regulatory requirements.
MEXICO → India corridor analysisMar 2026
Quality Testing & Batch Certification for Imports
MEXICO → India trade corridor intelligence
1Quality Testing & Batch Certification for Imports
Imported Paracetamol formulations must undergo stringent quality testing to ensure compliance with Indian standards:
- 1CDSCO-Approved Laboratories: Conduct batch testing in laboratories recognized by CDSCO.
- 2Batch-Wise Requirements: Each batch must be accompanied by a Certificate of Analysis (CoA) detailing test results.
- 3Stability Data: Provide stability data adhering to International Council for Harmonisation (ICH) guidelines, specifically for Zone IV conditions.
- 4Indian Pharmacopoeia Standards: Ensure formulations meet the standards set forth in the Indian Pharmacopoeia.
- 5Port Inspection: Customs drug inspectors perform inspections at ports to verify compliance with regulatory standards.
MEXICO → India corridor analysisMar 2026
Recent Import Policy Changes (2024-2026)
MEXICO → India trade corridor intelligence
1Recent Import Policy Changes (2024-2026)
Recent developments impacting the import of finished Paracetamol formulations into India include:
- 1CDSCO Regulatory Updates: Implementation of stricter guidelines for the importation of pharmaceutical products, emphasizing quality and safety.
- 2PLI Scheme Impact: The Production Linked Incentive (PLI) scheme has incentivized domestic production, potentially affecting the volume of imports.
- 3Bilateral Agreements: Ongoing negotiations between India and Mexico aim to streamline trade processes and enhance pharmaceutical trade relations.
MARKET
MEXICO → India corridor analysisMar 2026
India's Paracetamol Import Demand
MEXICO → India trade corridor intelligence
1India's Paracetamol Import Demand
India imports finished Paracetamol formulations to meet specific market needs:
- 1Patented/Branded Formulations: Imported formulations often include patented or branded products not available domestically.
- 2Specific Dosage Forms: Certain dosage forms, such as extended-release tablets or pediatric syrups, may not be produced locally.
- 3Domestic Capacity vs. Import Dependency: While India has a robust pharmaceutical manufacturing sector, imports supplement domestic production to fulfill diverse consumer demands.
- 4Market Size: The Indian Paracetamol market is substantial, with a significant portion of demand met through imports.
MEXICO → India corridor analysisMar 2026
India's Import Duty & Customs Structure
MEXICO → India trade corridor intelligence
1India's Import Duty & Customs Structure
The import duty structure for Paracetamol formulations under HS Code 30049069 is as follows:
- 1Basic Customs Duty (BCD): 10%
- 2Social Welfare Surcharge (SWS): 10% of BCD
- 3Integrated Goods and Services Tax (IGST): 12%
- 4Anti-Dumping Duty: Not applicable
- 5Exemption Notifications: No specific exemptions for Mexico-origin products
- 6Total Landed Duty: Approximately 32%
MEXICO → India corridor analysisMar 2026
Mexico as a Source — Competitive Position
MEXICO → India trade corridor intelligence
1Mexico as a Source — Competitive Position
India sources finished Paracetamol formulations from Mexico due to:
- 1Competitive Advantage: Mexico offers formulations with unique patents and specialized dosage forms not available from other suppliers.
- 2Quality Assurance: Mexican manufacturers adhere to international quality standards, ensuring product reliability.
- 3Other Suppliers: China, Germany, and the United States are also key suppliers, but Mexico's offerings provide distinct advantages.
- 4Mexico's Share: While specific market share data is unavailable, Mexico maintains a notable presence in India's pharmaceutical import market.
CORRIDOR
MEXICO → India corridor analysisMar 2026
Live Corridor Intelligence
MEXICO → India trade corridor intelligence
1Live Corridor Intelligence
The Mexico to India trade corridor for pharmaceutical imports is characterized by:
- 1Port Congestion: Major ports like Jawaharlal Nehru Port Trust (JNPT), Chennai, and Mundra experience moderate congestion, potentially affecting shipment timelines.
- 2Freight Rates: Sea freight rates fluctuate based on global demand and fuel prices; air freight remains a premium option.
- 3Currency Exchange: The Indian Rupee (INR) to Mexican Peso exchange rate influences the cost dynamics of imports.
MEXICO → India corridor analysisMar 2026
India's Import Policy & Self-Reliance Push
MEXICO → India trade corridor intelligence
1India's Import Policy & Self-Reliance Push
India's self-reliance initiatives, such as the Atmanirbhar Bharat Abhiyan, impact the import of finished formulations:
- 1PLI Scheme Impact: The Production Linked Incentive (PLI) scheme encourages domestic manufacturing, potentially reducing reliance on imports.
- 2Import Substitution Policies: Policies aim to boost local production capabilities, affecting the volume of imports from countries like Mexico.
- 3Reducing Import Dependency: Efforts are underway to decrease dependency on imports by enhancing domestic production and innovation.
MEXICO → India corridor analysisMar 2026
Bilateral Trade Relations
MEXICO → India trade corridor intelligence
1Bilateral Trade Relations
India and Mexico share a growing trade relationship in the pharmaceutical sector:
- 1Trade Agreements: Both nations are exploring agreements to facilitate smoother trade processes.
- 2Mutual GMP Recognition: Discussions are ongoing to recognize each other's Good Manufacturing Practices (GMP) certifications, enhancing trade efficiency.
- 3Pharma Trade Facilitation: Initiatives aim to streamline regulatory procedures, benefiting pharmaceutical trade between the two countries.
MEXICO → India corridor analysisMar 2026
Landed Cost Estimate (Mexico to India)
MEXICO → India trade corridor intelligence
1Landed Cost Estimate (Mexico to India)
The estimated landed cost for importing finished Paracetamol formulations from Mexico to India includes:
- 1FOB from Mexico: $686,300
- 2Freight: Approximately $20,000
- 3Insurance: $5,000
- 4Basic Customs Duty: $68,630
- 5Social Welfare Surcharge: $6,863
- 6IGST: $82,356
- 7Port Handling: $2,000
- 8Customs House Agent (CHA) Charges: $1,000
Total Landed Cost: Approximately $871,149
SOURCING
MEXICO → India corridor analysisMar 2026
Why India Imports Paracetamol from Mexico
MEXICO → India trade corridor intelligence
1Why India Imports Paracetamol from Mexico
India imports Paracetamol formulations from Mexico due to:
- 1Strategic Reasons: Access to unique formulations and patents not available domestically.
- 2Patented Formulations: Availability of branded products with established market presence.
- 3Specialized Dosage Forms: Specific formulations catering to diverse
MEXICO → India corridor analysisMar 2026
India's Import Regulations for Paracetamol from MEXICO
CDSCO registration, import licensing, and quality testing requirements
1India Import License & CDSCO Registration
To import finished pharmaceutical formulations containing Paracetamol (HS Code 30049069) into India, the following regulatory steps are mandatory:
- 1Import License: Obtain an Importer Exporter Code (IEC) from the Directorate General of Foreign Trade (DGFT).
- 2CDSCO Registration: Secure registration from the Central Drugs Standard Control Organisation (CDSCO) for the specific formulation.
- 3Form CT-20/40/41: Depending on the product type, submit the appropriate application form to CDSCO.
- 4DCGI Approval: Ensure approval from the Drugs Controller General of India (DCGI) for the imported product.
- 5No Objection Certificate (NOC): If required, obtain an NOC from the Ministry of Health and Family Welfare.
The registration process typically spans 6 to 12 months, contingent upon the completeness of the application and compliance with all regulatory requirements.
2Quality Testing & Batch Certification for Imports
Imported Paracetamol formulations must undergo stringent quality testing to ensure compliance with Indian standards:
- 1CDSCO-Approved Laboratories: Conduct batch testing in laboratories recognized by CDSCO.
- 2Batch-Wise Requirements: Each batch must be accompanied by a Certificate of Analysis (CoA) detailing test results.
- 3Stability Data: Provide stability data adhering to International Council for Harmonisation (ICH) guidelines, specifically for Zone IV conditions.
- 4Indian Pharmacopoeia Standards: Ensure formulations meet the standards set forth in the Indian Pharmacopoeia.
- 5Port Inspection: Customs drug inspectors perform inspections at ports to verify compliance with regulatory standards.
3Recent Import Policy Changes (2024-2026)
Recent developments impacting the import of finished Paracetamol formulations into India include:
- 1CDSCO Regulatory Updates: Implementation of stricter guidelines for the importation of pharmaceutical products, emphasizing quality and safety.
- 2PLI Scheme Impact: The Production Linked Incentive (PLI) scheme has incentivized domestic production, potentially affecting the volume of imports.
- 3Bilateral Agreements: Ongoing negotiations between India and Mexico aim to streamline trade processes and enhance pharmaceutical trade relations.
MARKET
4India's Paracetamol Import Demand
India imports finished Paracetamol formulations to meet specific market needs:
- 1Patented/Branded Formulations: Imported formulations often include patented or branded products not available domestically.
- 2Specific Dosage Forms: Certain dosage forms, such as extended-release tablets or pediatric syrups, may not be produced locally.
- 3Domestic Capacity vs. Import Dependency: While India has a robust pharmaceutical manufacturing sector, imports supplement domestic production to fulfill diverse consumer demands.
- 4Market Size: The Indian Paracetamol market is substantial, with a significant portion of demand met through imports.
5India's Import Duty & Customs Structure
The import duty structure for Paracetamol formulations under HS Code 30049069 is as follows:
- 1Basic Customs Duty (BCD): 10%
- 2Social Welfare Surcharge (SWS): 10% of BCD
- 3Integrated Goods and Services Tax (IGST): 12%
- 4Anti-Dumping Duty: Not applicable
- 5Exemption Notifications: No specific exemptions for Mexico-origin products
- 6Total Landed Duty: Approximately 32%
6Mexico as a Source — Competitive Position
India sources finished Paracetamol formulations from Mexico due to:
- 1Competitive Advantage: Mexico offers formulations with unique patents and specialized dosage forms not available from other suppliers.
- 2Quality Assurance: Mexican manufacturers adhere to international quality standards, ensuring product reliability.
- 3Other Suppliers: China, Germany, and the United States are also key suppliers, but Mexico's offerings provide distinct advantages.
- 4Mexico's Share: While specific market share data is unavailable, Mexico maintains a notable presence in India's pharmaceutical import market.
CORRIDOR
7Live Corridor Intelligence
The Mexico to India trade corridor for pharmaceutical imports is characterized by:
- 1Port Congestion: Major ports like Jawaharlal Nehru Port Trust (JNPT), Chennai, and Mundra experience moderate congestion, potentially affecting shipment timelines.
- 2Freight Rates: Sea freight rates fluctuate based on global demand and fuel prices; air freight remains a premium option.
- 3Currency Exchange: The Indian Rupee (INR) to Mexican Peso exchange rate influences the cost dynamics of imports.
8India's Import Policy & Self-Reliance Push
India's self-reliance initiatives, such as the Atmanirbhar Bharat Abhiyan, impact the import of finished formulations:
- 1PLI Scheme Impact: The Production Linked Incentive (PLI) scheme encourages domestic manufacturing, potentially reducing reliance on imports.
- 2Import Substitution Policies: Policies aim to boost local production capabilities, affecting the volume of imports from countries like Mexico.
- 3Reducing Import Dependency: Efforts are underway to decrease dependency on imports by enhancing domestic production and innovation.
9Bilateral Trade Relations
India and Mexico share a growing trade relationship in the pharmaceutical sector:
- 1Trade Agreements: Both nations are exploring agreements to facilitate smoother trade processes.
- 2Mutual GMP Recognition: Discussions are ongoing to recognize each other's Good Manufacturing Practices (GMP) certifications, enhancing trade efficiency.
- 3Pharma Trade Facilitation: Initiatives aim to streamline regulatory procedures, benefiting pharmaceutical trade between the two countries.
10Landed Cost Estimate (Mexico to India)
The estimated landed cost for importing finished Paracetamol formulations from Mexico to India includes:
- 1FOB from Mexico: $686,300
- 2Freight: Approximately $20,000
- 3Insurance: $5,000
- 4Basic Customs Duty: $68,630
- 5Social Welfare Surcharge: $6,863
- 6IGST: $82,356
- 7Port Handling: $2,000
- 8Customs House Agent (CHA) Charges: $1,000
Total Landed Cost: Approximately $871,149
SOURCING
11Why India Imports Paracetamol from Mexico
India imports Paracetamol formulations from Mexico due to:
- 1Strategic Reasons: Access to unique formulations and patents not available domestically.
- 2Patented Formulations: Availability of branded products with established market presence.
- 3Specialized Dosage Forms: Specific formulations catering to diverse
CDSCO/DGFT pharmaceutical import regulatory analysisMar 2026
India's Paracetamol Import Market & Tariffs
Market demand, customs duty structure, and competitive landscape
1India Import License & CDSCO Registration
To import finished pharmaceutical formulations containing Paracetamol (HS Code 30049069) into India, the following regulatory steps are mandatory:
- 1Import License: Obtain an Importer Exporter Code (IEC) from the Directorate General of Foreign Trade (DGFT).
- 2CDSCO Registration: Secure registration from the Central Drugs Standard Control Organisation (CDSCO) for the specific formulation.
- 3Form CT-20/40/41: Depending on the product type, submit the appropriate application form to CDSCO.
- 4DCGI Approval: Ensure approval from the Drugs Controller General of India (DCGI) for the imported product.
- 5No Objection Certificate (NOC): If required, obtain an NOC from the Ministry of Health and Family Welfare.
The registration process typically spans 6 to 12 months, contingent upon the completeness of the application and compliance with all regulatory requirements.
2Quality Testing & Batch Certification for Imports
Imported Paracetamol formulations must undergo stringent quality testing to ensure compliance with Indian standards:
- 1CDSCO-Approved Laboratories: Conduct batch testing in laboratories recognized by CDSCO.
- 2Batch-Wise Requirements: Each batch must be accompanied by a Certificate of Analysis (CoA) detailing test results.
- 3Stability Data: Provide stability data adhering to International Council for Harmonisation (ICH) guidelines, specifically for Zone IV conditions.
- 4Indian Pharmacopoeia Standards: Ensure formulations meet the standards set forth in the Indian Pharmacopoeia.
- 5Port Inspection: Customs drug inspectors perform inspections at ports to verify compliance with regulatory standards.
3Recent Import Policy Changes (2024-2026)
Recent developments impacting the import of finished Paracetamol formulations into India include:
- 1CDSCO Regulatory Updates: Implementation of stricter guidelines for the importation of pharmaceutical products, emphasizing quality and safety.
- 2PLI Scheme Impact: The Production Linked Incentive (PLI) scheme has incentivized domestic production, potentially affecting the volume of imports.
- 3Bilateral Agreements: Ongoing negotiations between India and Mexico aim to streamline trade processes and enhance pharmaceutical trade relations.
MARKET
4India's Paracetamol Import Demand
India imports finished Paracetamol formulations to meet specific market needs:
- 1Patented/Branded Formulations: Imported formulations often include patented or branded products not available domestically.
- 2Specific Dosage Forms: Certain dosage forms, such as extended-release tablets or pediatric syrups, may not be produced locally.
- 3Domestic Capacity vs. Import Dependency: While India has a robust pharmaceutical manufacturing sector, imports supplement domestic production to fulfill diverse consumer demands.
- 4Market Size: The Indian Paracetamol market is substantial, with a significant portion of demand met through imports.
5India's Import Duty & Customs Structure
The import duty structure for Paracetamol formulations under HS Code 30049069 is as follows:
- 1Basic Customs Duty (BCD): 10%
- 2Social Welfare Surcharge (SWS): 10% of BCD
- 3Integrated Goods and Services Tax (IGST): 12%
- 4Anti-Dumping Duty: Not applicable
- 5Exemption Notifications: No specific exemptions for Mexico-origin products
- 6Total Landed Duty: Approximately 32%
6Mexico as a Source — Competitive Position
India sources finished Paracetamol formulations from Mexico due to:
- 1Competitive Advantage: Mexico offers formulations with unique patents and specialized dosage forms not available from other suppliers.
- 2Quality Assurance: Mexican manufacturers adhere to international quality standards, ensuring product reliability.
- 3Other Suppliers: China, Germany, and the United States are also key suppliers, but Mexico's offerings provide distinct advantages.
- 4Mexico's Share: While specific market share data is unavailable, Mexico maintains a notable presence in India's pharmaceutical import market.
CORRIDOR
7Live Corridor Intelligence
The Mexico to India trade corridor for pharmaceutical imports is characterized by:
- 1Port Congestion: Major ports like Jawaharlal Nehru Port Trust (JNPT), Chennai, and Mundra experience moderate congestion, potentially affecting shipment timelines.
- 2Freight Rates: Sea freight rates fluctuate based on global demand and fuel prices; air freight remains a premium option.
- 3Currency Exchange: The Indian Rupee (INR) to Mexican Peso exchange rate influences the cost dynamics of imports.
8India's Import Policy & Self-Reliance Push
India's self-reliance initiatives, such as the Atmanirbhar Bharat Abhiyan, impact the import of finished formulations:
- 1PLI Scheme Impact: The Production Linked Incentive (PLI) scheme encourages domestic manufacturing, potentially reducing reliance on imports.
- 2Import Substitution Policies: Policies aim to boost local production capabilities, affecting the volume of imports from countries like Mexico.
- 3Reducing Import Dependency: Efforts are underway to decrease dependency on imports by enhancing domestic production and innovation.
9Bilateral Trade Relations
India and Mexico share a growing trade relationship in the pharmaceutical sector:
- 1Trade Agreements: Both nations are exploring agreements to facilitate smoother trade processes.
- 2Mutual GMP Recognition: Discussions are ongoing to recognize each other's Good Manufacturing Practices (GMP) certifications, enhancing trade efficiency.
- 3Pharma Trade Facilitation: Initiatives aim to streamline regulatory procedures, benefiting pharmaceutical trade between the two countries.
10Landed Cost Estimate (Mexico to India)
The estimated landed cost for importing finished Paracetamol formulations from Mexico to India includes:
- 1FOB from Mexico: $686,300
- 2Freight: Approximately $20,000
- 3Insurance: $5,000
- 4Basic Customs Duty: $68,630
- 5Social Welfare Surcharge: $6,863
- 6IGST: $82,356
- 7Port Handling: $2,000
- 8Customs House Agent (CHA) Charges: $1,000
Total Landed Cost: Approximately $871,149
SOURCING
11Why India Imports Paracetamol from Mexico
India imports Paracetamol formulations from Mexico due to:
- 1Strategic Reasons: Access to unique formulations and patents not available domestically.
- 2Patented Formulations: Availability of branded products with established market presence.
- 3Specialized Dosage Forms: Specific formulations catering to diverse
India Paracetamol import market analysisMar 2026
Why India Imports Paracetamol from MEXICO
Import rationale, competitive comparison, supply chain risk, and procurement strategy
1India Import License & CDSCO Registration
To import finished pharmaceutical formulations containing Paracetamol (HS Code 30049069) into India, the following regulatory steps are mandatory:
- 1Import License: Obtain an Importer Exporter Code (IEC) from the Directorate General of Foreign Trade (DGFT).
- 2CDSCO Registration: Secure registration from the Central Drugs Standard Control Organisation (CDSCO) for the specific formulation.
- 3Form CT-20/40/41: Depending on the product type, submit the appropriate application form to CDSCO.
- 4DCGI Approval: Ensure approval from the Drugs Controller General of India (DCGI) for the imported product.
- 5No Objection Certificate (NOC): If required, obtain an NOC from the Ministry of Health and Family Welfare.
The registration process typically spans 6 to 12 months, contingent upon the completeness of the application and compliance with all regulatory requirements.
2Quality Testing & Batch Certification for Imports
Imported Paracetamol formulations must undergo stringent quality testing to ensure compliance with Indian standards:
- 1CDSCO-Approved Laboratories: Conduct batch testing in laboratories recognized by CDSCO.
- 2Batch-Wise Requirements: Each batch must be accompanied by a Certificate of Analysis (CoA) detailing test results.
- 3Stability Data: Provide stability data adhering to International Council for Harmonisation (ICH) guidelines, specifically for Zone IV conditions.
- 4Indian Pharmacopoeia Standards: Ensure formulations meet the standards set forth in the Indian Pharmacopoeia.
- 5Port Inspection: Customs drug inspectors perform inspections at ports to verify compliance with regulatory standards.
3Recent Import Policy Changes (2024-2026)
Recent developments impacting the import of finished Paracetamol formulations into India include:
- 1CDSCO Regulatory Updates: Implementation of stricter guidelines for the importation of pharmaceutical products, emphasizing quality and safety.
- 2PLI Scheme Impact: The Production Linked Incentive (PLI) scheme has incentivized domestic production, potentially affecting the volume of imports.
- 3Bilateral Agreements: Ongoing negotiations between India and Mexico aim to streamline trade processes and enhance pharmaceutical trade relations.
MARKET
4India's Paracetamol Import Demand
India imports finished Paracetamol formulations to meet specific market needs:
- 1Patented/Branded Formulations: Imported formulations often include patented or branded products not available domestically.
- 2Specific Dosage Forms: Certain dosage forms, such as extended-release tablets or pediatric syrups, may not be produced locally.
- 3Domestic Capacity vs. Import Dependency: While India has a robust pharmaceutical manufacturing sector, imports supplement domestic production to fulfill diverse consumer demands.
- 4Market Size: The Indian Paracetamol market is substantial, with a significant portion of demand met through imports.
5India's Import Duty & Customs Structure
The import duty structure for Paracetamol formulations under HS Code 30049069 is as follows:
- 1Basic Customs Duty (BCD): 10%
- 2Social Welfare Surcharge (SWS): 10% of BCD
- 3Integrated Goods and Services Tax (IGST): 12%
- 4Anti-Dumping Duty: Not applicable
- 5Exemption Notifications: No specific exemptions for Mexico-origin products
- 6Total Landed Duty: Approximately 32%
6Mexico as a Source — Competitive Position
India sources finished Paracetamol formulations from Mexico due to:
- 1Competitive Advantage: Mexico offers formulations with unique patents and specialized dosage forms not available from other suppliers.
- 2Quality Assurance: Mexican manufacturers adhere to international quality standards, ensuring product reliability.
- 3Other Suppliers: China, Germany, and the United States are also key suppliers, but Mexico's offerings provide distinct advantages.
- 4Mexico's Share: While specific market share data is unavailable, Mexico maintains a notable presence in India's pharmaceutical import market.
CORRIDOR
7Live Corridor Intelligence
The Mexico to India trade corridor for pharmaceutical imports is characterized by:
- 1Port Congestion: Major ports like Jawaharlal Nehru Port Trust (JNPT), Chennai, and Mundra experience moderate congestion, potentially affecting shipment timelines.
- 2Freight Rates: Sea freight rates fluctuate based on global demand and fuel prices; air freight remains a premium option.
- 3Currency Exchange: The Indian Rupee (INR) to Mexican Peso exchange rate influences the cost dynamics of imports.
8India's Import Policy & Self-Reliance Push
India's self-reliance initiatives, such as the Atmanirbhar Bharat Abhiyan, impact the import of finished formulations:
- 1PLI Scheme Impact: The Production Linked Incentive (PLI) scheme encourages domestic manufacturing, potentially reducing reliance on imports.
- 2Import Substitution Policies: Policies aim to boost local production capabilities, affecting the volume of imports from countries like Mexico.
- 3Reducing Import Dependency: Efforts are underway to decrease dependency on imports by enhancing domestic production and innovation.
9Bilateral Trade Relations
India and Mexico share a growing trade relationship in the pharmaceutical sector:
- 1Trade Agreements: Both nations are exploring agreements to facilitate smoother trade processes.
- 2Mutual GMP Recognition: Discussions are ongoing to recognize each other's Good Manufacturing Practices (GMP) certifications, enhancing trade efficiency.
- 3Pharma Trade Facilitation: Initiatives aim to streamline regulatory procedures, benefiting pharmaceutical trade between the two countries.
10Landed Cost Estimate (Mexico to India)
The estimated landed cost for importing finished Paracetamol formulations from Mexico to India includes:
- 1FOB from Mexico: $686,300
- 2Freight: Approximately $20,000
- 3Insurance: $5,000
- 4Basic Customs Duty: $68,630
- 5Social Welfare Surcharge: $6,863
- 6IGST: $82,356
- 7Port Handling: $2,000
- 8Customs House Agent (CHA) Charges: $1,000
Total Landed Cost: Approximately $871,149
SOURCING
11Why India Imports Paracetamol from Mexico
India imports Paracetamol formulations from Mexico due to:
- 1Strategic Reasons: Access to unique formulations and patents not available domestically.
- 2Patented Formulations: Availability of branded products with established market presence.
- 3Specialized Dosage Forms: Specific formulations catering to diverse
MEXICO → India pharmaceutical sourcing analysisMar 2026
Import Due Diligence — Paracetamol from MEXICO
Import license checklist, document requirements, quality testing, and compliance
1India Import License & CDSCO Registration
To import finished pharmaceutical formulations containing Paracetamol (HS Code 30049069) into India, the following regulatory steps are mandatory:
- 1Import License: Obtain an Importer Exporter Code (IEC) from the Directorate General of Foreign Trade (DGFT).
- 2CDSCO Registration: Secure registration from the Central Drugs Standard Control Organisation (CDSCO) for the specific formulation.
- 3Form CT-20/40/41: Depending on the product type, submit the appropriate application form to CDSCO.
- 4DCGI Approval: Ensure approval from the Drugs Controller General of India (DCGI) for the imported product.
- 5No Objection Certificate (NOC): If required, obtain an NOC from the Ministry of Health and Family Welfare.
The registration process typically spans 6 to 12 months, contingent upon the completeness of the application and compliance with all regulatory requirements.
2Quality Testing & Batch Certification for Imports
Imported Paracetamol formulations must undergo stringent quality testing to ensure compliance with Indian standards:
- 1CDSCO-Approved Laboratories: Conduct batch testing in laboratories recognized by CDSCO.
- 2Batch-Wise Requirements: Each batch must be accompanied by a Certificate of Analysis (CoA) detailing test results.
- 3Stability Data: Provide stability data adhering to International Council for Harmonisation (ICH) guidelines, specifically for Zone IV conditions.
- 4Indian Pharmacopoeia Standards: Ensure formulations meet the standards set forth in the Indian Pharmacopoeia.
- 5Port Inspection: Customs drug inspectors perform inspections at ports to verify compliance with regulatory standards.
3Recent Import Policy Changes (2024-2026)
Recent developments impacting the import of finished Paracetamol formulations into India include:
- 1CDSCO Regulatory Updates: Implementation of stricter guidelines for the importation of pharmaceutical products, emphasizing quality and safety.
- 2PLI Scheme Impact: The Production Linked Incentive (PLI) scheme has incentivized domestic production, potentially affecting the volume of imports.
- 3Bilateral Agreements: Ongoing negotiations between India and Mexico aim to streamline trade processes and enhance pharmaceutical trade relations.
MARKET
4India's Paracetamol Import Demand
India imports finished Paracetamol formulations to meet specific market needs:
- 1Patented/Branded Formulations: Imported formulations often include patented or branded products not available domestically.
- 2Specific Dosage Forms: Certain dosage forms, such as extended-release tablets or pediatric syrups, may not be produced locally.
- 3Domestic Capacity vs. Import Dependency: While India has a robust pharmaceutical manufacturing sector, imports supplement domestic production to fulfill diverse consumer demands.
- 4Market Size: The Indian Paracetamol market is substantial, with a significant portion of demand met through imports.
5India's Import Duty & Customs Structure
The import duty structure for Paracetamol formulations under HS Code 30049069 is as follows:
- 1Basic Customs Duty (BCD): 10%
- 2Social Welfare Surcharge (SWS): 10% of BCD
- 3Integrated Goods and Services Tax (IGST): 12%
- 4Anti-Dumping Duty: Not applicable
- 5Exemption Notifications: No specific exemptions for Mexico-origin products
- 6Total Landed Duty: Approximately 32%
6Mexico as a Source — Competitive Position
India sources finished Paracetamol formulations from Mexico due to:
- 1Competitive Advantage: Mexico offers formulations with unique patents and specialized dosage forms not available from other suppliers.
- 2Quality Assurance: Mexican manufacturers adhere to international quality standards, ensuring product reliability.
- 3Other Suppliers: China, Germany, and the United States are also key suppliers, but Mexico's offerings provide distinct advantages.
- 4Mexico's Share: While specific market share data is unavailable, Mexico maintains a notable presence in India's pharmaceutical import market.
CORRIDOR
7Live Corridor Intelligence
The Mexico to India trade corridor for pharmaceutical imports is characterized by:
- 1Port Congestion: Major ports like Jawaharlal Nehru Port Trust (JNPT), Chennai, and Mundra experience moderate congestion, potentially affecting shipment timelines.
- 2Freight Rates: Sea freight rates fluctuate based on global demand and fuel prices; air freight remains a premium option.
- 3Currency Exchange: The Indian Rupee (INR) to Mexican Peso exchange rate influences the cost dynamics of imports.
8India's Import Policy & Self-Reliance Push
India's self-reliance initiatives, such as the Atmanirbhar Bharat Abhiyan, impact the import of finished formulations:
- 1PLI Scheme Impact: The Production Linked Incentive (PLI) scheme encourages domestic manufacturing, potentially reducing reliance on imports.
- 2Import Substitution Policies: Policies aim to boost local production capabilities, affecting the volume of imports from countries like Mexico.
- 3Reducing Import Dependency: Efforts are underway to decrease dependency on imports by enhancing domestic production and innovation.
9Bilateral Trade Relations
India and Mexico share a growing trade relationship in the pharmaceutical sector:
- 1Trade Agreements: Both nations are exploring agreements to facilitate smoother trade processes.
- 2Mutual GMP Recognition: Discussions are ongoing to recognize each other's Good Manufacturing Practices (GMP) certifications, enhancing trade efficiency.
- 3Pharma Trade Facilitation: Initiatives aim to streamline regulatory procedures, benefiting pharmaceutical trade between the two countries.
10Landed Cost Estimate (Mexico to India)
The estimated landed cost for importing finished Paracetamol formulations from Mexico to India includes:
- 1FOB from Mexico: $686,300
- 2Freight: Approximately $20,000
- 3Insurance: $5,000
- 4Basic Customs Duty: $68,630
- 5Social Welfare Surcharge: $6,863
- 6IGST: $82,356
- 7Port Handling: $2,000
- 8Customs House Agent (CHA) Charges: $1,000
Total Landed Cost: Approximately $871,149
SOURCING
11Why India Imports Paracetamol from Mexico
India imports Paracetamol formulations from Mexico due to:
- 1Strategic Reasons: Access to unique formulations and patents not available domestically.
- 2Patented Formulations: Availability of branded products with established market presence.
- 3Specialized Dosage Forms: Specific formulations catering to diverse
Indian pharmaceutical import compliance guidanceMar 2026
Frequently Asked Questions — Paracetamol Imports from MEXICO
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Paracetamol suppliers from MEXICO to India?
The top Paracetamol suppliers from MEXICO to India include HELM DE MEXICO S.A. The leading supplier is HELM DE MEXICO S.A with import value of $686.3K USD across 27 shipments. India imported Paracetamol worth $686.3K USD from MEXICO in total across 27 shipments.
QHow much Paracetamol does India import from MEXICO?
India imported Paracetamol worth $686.3K USD from MEXICO across 27 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Paracetamol from MEXICO?
The main Indian buyers of Paracetamol sourced from MEXICO include SRI KRISHNA PHARMACEUTICALS LIMITED. The largest buyer is SRI KRISHNA PHARMACEUTICALS LIMITED with $686.3K in imports across 27 shipments.
QWhat is the total value of Paracetamol imports from MEXICO to India?
The total value of Paracetamol imports from MEXICO to India is $686.3K USD, across 27 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: MEXICO to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Paracetamol.
- 2.Supplier/Buyer Matching: 1 foreign suppliers from MEXICO and 1 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $686.3K aggregated from 27 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
27 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists